|
Sign In to gain access to subscriptions and/or personal tools.
|
Cardiovascular disease in type 2 diabetes: targets, risks and patients
Ken Taylor
Department of Diabetes, Endocrinology and Lipid Metabolism, City Hospital, Dudley Road, Birmingham, B18 7QH, UK, k.taylor{at}hospital-doctor.net
References
- European Diabetes Policy Group. A Desktop Guide to Type 2 Diabetes Mellitus. Diabetic Med 1999;16:716-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.[Abstract/Free Full Text]
- UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-15.[Abstract/Free Full Text]
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Krentz AJ, Bailey CJ Type 2 Diabetes in Practice. London: Royal Society of Medicine Press, 2001, pp 153-74.
- Kirby M. Statin status. Br J Diabetes Vasc Dis 2001;1:102.[Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 3,
195-197 (2002)
DOI: 10.1177/14746514020020030901

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|